Henry Schein, Inc. (NASDAQ:HSIC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Henry Schein, Inc. (NASDAQ:HSIC) has been given an average recommendation of “Moderate Buy” by the thirteen analysts that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $81.67.

A number of analysts recently weighed in on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. Robert W. Baird upgraded Henry Schein from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $81.00 to $92.00 in a research note on Monday. UBS Group lowered their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Barrington Research reaffirmed an “outperform” rating and set a $92.00 target price on shares of Henry Schein in a report on Friday, July 5th. Finally, Evercore ISI lowered their price target on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th.

Institutional Investors Weigh In On Henry Schein

Hedge funds and other institutional investors have recently bought and sold shares of the business. Fifth Third Bancorp increased its stake in Henry Schein by 41.8% in the 2nd quarter. Fifth Third Bancorp now owns 2,793 shares of the company’s stock worth $179,000 after purchasing an additional 824 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in Henry Schein in the 2nd quarter worth approximately $3,681,000. First Citizens Bank & Trust Co. lifted its stake in shares of Henry Schein by 12.6% in the second quarter. First Citizens Bank & Trust Co. now owns 49,993 shares of the company’s stock worth $3,205,000 after buying an additional 5,585 shares during the last quarter. Raymond James & Associates lifted its position in Henry Schein by 2.0% during the 2nd quarter. Raymond James & Associates now owns 292,166 shares of the company’s stock worth $18,728,000 after acquiring an additional 5,763 shares during the last quarter. Finally, TCW Group Inc. lifted its position in shares of Henry Schein by 72.6% during the 2nd quarter. TCW Group Inc. now owns 24,740 shares of the company’s stock worth $1,586,000 after purchasing an additional 10,407 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

HSIC stock opened at $70.29 on Friday. The stock has a market capitalization of $9.00 billion, a price-to-earnings ratio of 23.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.87. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. Henry Schein has a 52-week low of $60.01 and a 52-week high of $82.63. The stock’s fifty day simple moving average is $68.28 and its 200-day simple moving average is $71.92.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.21 EPS. Equities research analysts expect that Henry Schein will post 5.16 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.